(Clivatuzumab)Biosimilar Reference Antibody-GS40140 新品

货号：GS40140

Clivatuzumab is a humanized anti-mucin monoclonal antibody developed as a targeted therapy for pancreatic cancer. It is designed to specifically recognize and bind to a distinct epitope on the mucin protein that is overexpressed on the surface of malignant cells. By targeting this tumor-associated antigen, the antibody aims to deliver its therapeutic payload (such as a cytotoxic drug or radioisotope in an ADC format) or mediate immune effector functions directly to pancreatic tumor cells, sparing healthy tissues.